What condition is Holoclar approved to treat in adults?

Holoclar treats adults with moderate-to-severe limbal stem cell deficiency in one or both eyes due to physical or chemical ocular burns, defined by superficial corneal neovascularisation in at least two quadrants, central corneal involvement and severely impaired visual acuity, with at least 1–2 mm² of undamaged limbus required for biopsy.